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Abstract
Microorganisms within the gastrointestinal tract significantly influence metabolic processes within their mammalian host,
and recently several groups have sought to characterise the gastrointestinal microbiota of individuals affected by metabolic
disease. Differences in the composition of the gastrointestinal microbiota have been reported in mouse models of type 2
diabetes mellitus, as well as in human patients. Diabetes mellitus in cats has many similarities to type 2 diabetes in humans.
No studies of the gastrointestinal microbiota of diabetic cats have been previously published. The objectives of this study
were to compare the composition of the faecal microbiota of diabetic and non-diabetic cats, and secondarily to determine if
host signalment and dietary factors influence the composition of the faecal microbiota in cats. Faecal samples were
collected from insulin-treated diabetic and non-diabetic cats, and Illumina sequencing of the 16S rRNA gene and
quantitative PCR were performed on each sample. ANOSIM based on the unweighted UniFrac distance metric identified no
difference in the composition of the faecal microbiota between diabetic and non-diabetic cats, and no significant
differences in the proportions of dominant bacteria by phylum, class, order, family or genus as determined by 16S rRNA
gene sequencing were identified between diabetic and non-diabetic cats. qPCR identified a decrease in Faecalibacterium
spp. in cats aged over ten years. Cat breed or gender, dietary carbohydrate, protein or fat content, and dietary formulation
(wet versus dry food) did not affect the composition of the faecal microbiota. In conclusion, the composition of the faecal
microbiota was not altered by the presence of diabetes mellitus in cats. Additional studies that compare the functional
products of the microbiota in diabetic and non-diabetic cats are warranted to further investigate the potential impact of the
gastrointestinal microbiota on metabolic diseases such as diabetes mellitus in cats.
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Introduction
The presence of microorganisms within the mammalian
gastrointestinal tract has important consequences for the host,
both immunologic and metabolic. Immunologic effects have been
recently reviewed [1]. Metabolic effects are largely due to the
ability of microorganisms to utilise dietary components that are
not digested in the small intestine, such as complex carbohydrates,
which are fermented by colonic bacteria to generate short-chain
fatty acids such as butyrate, propionate and acetate. These
products represent a significant energy source for the host
(contributing up to 10% of daily energy requirements) [2,3],
which would otherwise not be available. The gastrointestinal
microbiota is also involved in the metabolism of peptides [4],
proteins [4] and bile acids [5], the synthesis of bioactive isomers of
conjugated linoleic acid that have anti-diabetogenic, anti-obeso-
genic and anti-atherogenic properties [6,7], and the regulation of
intestinal angiogenesis, epithelial cell proliferation and differenti-
ation [8,9]. There is significant variation in the composition of
gastrointestinal microbiota between individual animals at the
bacterial species and strain level [10–12]. However, despite this
variation the metabolic effects of the microbiota are maintained,
suggesting a functional overlap between resident microorganisms.
In acknowledgement of this influence on host metabolism, a
potential role for the microbiota in the pathogenesis of metabolic
disease has been proposed. Alterations in the composition or
functional properties of the microbiota could potentially affect the
efficiency of energy acquisition from the diet, intestinal perme-
ability or other metabolic processes within the host, which could in
turn influence an individual’s susceptibility to metabolic diseases
such as obesity and type 2 diabetes mellitus.
In the last decade, a number of studies have reported
compositional alterations in the microbiota of obese mice
compared with lean mice, with a higher proportion of organisms
from the Firmicutes phylum and a corresponding decrease in
organisms from the Bacteroidetes phylum associated with an obese
phenotype [13–15]. This observation is common to both genetic
and diet-induced models of obesity, and has also been shown to be
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reversible with weight loss [14]. Similarly, obesity in humans has
been associated with an increased proportion of Firmicutes and a
decreased proportion of Bacteroidetes [16,17]. Weight loss,
achieved by either diet or bariatric surgery, was inversely
correlated with the proportion of Bacteroidetes in two studies
[16,17]. However, a proportional shift in the opposite direction
(i.e. an increase in the ratio of Bacteroidetes to Firmicutes) has also
been reported in obese humans [18], as has no difference in the
relative proportions of these phyla [19]. In this latter study,
although the proportions of Firmicutes and Bacteroidetes were not
different between obese and lean people, faecal short chain fatty
acid concentration was significantly higher in the obese group.
This observation indicates that there may be functional differences
in the microbiome associated with obesity, and that these
differences can occur independently of compositional differences.
The composition of the microbiota of mice with type 2 diabetes
mellitus is also reported to be altered, with an increase in the ratio
of Bacteroidetes to Firmicutes being associated with this disease in
a mouse model of type 2 diabetes mellitus without obesity [20].
Similar differences in microbiota composition of humans with type
2 diabetes mellitus have been identified [21,22], with a reduced
proportion of Firmicutes and a positive correlation between the
ratio of Bacteroidetes to Firmicutes and plasma glucose concen-
tration described in one study [22].
Diabetes mellitus is a common endocrinopathy in cats, with an
estimated incidence of 0.5% in first opinion veterinary practice
[23]. There are two pathophysiological components of feline
diabetes mellitus: (i) reduced insulin secretion from dysfunctional
and/or lost pancreatic beta cells, and (ii) insulin resistance, making
this disease analogous to type 2 diabetes mellitus in humans [24].
No studies of the gastrointestinal microbiota of diabetic cats have
previously been published.
The aims of this study were to compare the faecal microbiota
composition of diabetic and non-diabetic cats, and secondarily to
determine if host signalment and dietary factors influence the
composition of the faecal microbiota in cats.
Materials and Methods
Ethics Statement
This study was approved by the University of Melbourne
Animal Ethics Committee, using National Health and Medical
Research Council (NHMRC) guidelines.
Animals and Sample Collection
All cats involved in this study were owned, pet cats. Cats were
diagnosed with diabetes mellitus on the basis of appropriate
clinical signs (polyuria, polydipsia, polyphagia and weight loss) and
clinical pathology findings (persistent hyperglycaemia and glucos-
uria). Both newly diagnosed and long-term diabetic cats were
considered for inclusion in the study. All diabetic cats received
exogenous insulin as one component of their therapy. Non-
diabetic cats were clinically healthy and had not been previously
diagnosed with diabetes mellitus. Non-diabetic cats were breed-,
age- (within three years) and sex-matched to diabetic cats.
Naturally voided faecal samples were collected from the diabetic
and non-diabetic cats at home or at a veterinary clinic. Samples
were refrigerated at 4uC until transport to the laboratory, which
was completed within 48 hours of sample collection. Samples were
then frozen at -20uC until processing.
Sequencing of 16S rRNA genes
An aliquot of 100 mg (wet weight) of each faecal sample was
extracted by a bead-beating method using a commercial DNA
extraction kit (ZR Fecal DNA Kit, Zymo Research Corporation)
following the manufacturer’s instructions. The bead beating step
was performed on a homogenizer (FastPrep-24, MP Biomedicals)
for 60 seconds at a speed of 4 metres per second.
The V4 region of the 16S rRNA gene was amplified with
primers 515F (59-GTGCCAGCMGCCGCGGTAA-39) and 806R
(59-GGACTACVSGGGTATCTAAT-39) at the MR DNA Lab-
oratory (Shallowater, TX, USA). A 100 ng (1 ml) aliquot of each
DNA sample was used for a 50 ml PCR reaction. HotStarTaq Plus
Master Mix Kit (Qiagen, Valencia, CA, USA) was used for PCR
under the following conditions: 94uC for 3 min followed by 32
cycles of 94uC for 30 sec; 60uC for 40 sec and 72uC for 1 min; and
a final elongation step at 72uC for 5 min. PCR amplification
products were verified on 2% agarose gels and samples were
purified using calibrated Ampure XP beads (Agencourt Bioscience
Corporation, Danvers, MA, USA). The Nextera DNA sample
Preparation kit including sequencing adapters and sample specific
barcodes was used to prepare a DNA library and sequenced at
MR DNA on an Illumina MiSeq instrument.
Quantitative PCR (qPCR)
To evaluate bacterial genera that are typically present at very
low abundance or not detected in sequence data based on our
experience from previous studies [12,25] we performed qPCR
assays for selected bacterial groups: total bacteria, Lactobacillus
spp., Bifidobacterium spp. and Faecalibacterium spp.. The
oligonucleotide sequence of primers and respective annealing
temperatures are summarised in Table 1. The DNA concentration
of all faecal samples was adjusted to 5 ng mL21. A commercial
real-time PCR thermocycler (CFX96TM, Biorad Laboratories,
Table 1. Oligonucleotide sequences of primers and annealing temperatures used for this study.
qPCR primers Sequence (59-39) Target Annealing (6C) Reference
BifF TCGCGTCYGGTGTGAAAG Bifidobacterium 60 [47]
BifR CCACATCCAGCRTCCAC
FaecaF GAAGGCGGCCTACTGGGCAC Faecalibacterium 60 [48]
FaecaR GTGCAGGCGAGTTGCAGCCT
LactF AGCAGTAGGGAATCTTCCA Lactobacillus 58 [47]
LactR CACCGCTACACATGGAG
341-F CCTACGGGAGGCAGCAGT Universal bacteria 59 [46]
518-R ATTACCGCGGCTGCTGG
doi:10.1371/journal.pone.0108729.t001
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Hercules, CA, USA) was used for all experiments. Standard curves
using 1:10 dilutions of DNA (ranging from 2 ng to 0.2 pg) from
lyophilized bacterial species of each genus (Faecalibacterium
prausnitzii (ATCC 27766); Lactobacillus rhamnosus GG (ATCC
53103); Bifidobacterium bifidum (ATCC 11863)) and feline fecal
community DNA for universal bacteria were used to calculate the
unknown bacterial genomic targets. All samples and standards
were run in duplicate. SYBR-based reaction mixtures (total 10 mL)
contained 5 mL of SsoFastTM EvaGreen supermix (Biorad
Laboratories, Hercules, CA, USA), 2.6 mL of water, 0.4 mL of
each primer (final concentration: 400 nM), and 2 mL of DNA
(1:10 or 1:100 dilution). PCR conditions were 95uC for 2 min, and
40 cycles at 95uC for 5 sec and 10 sec at the optimized annealing
temperature. After all PCR cycles were completed, a melt curve
analysis was performed for SYBR-based qPCR assays under the
following conditions: 1 min at 95uC, 1 min at 55uC, and 80 cycles
of 0.5uC increments (10 sec each). The qPCR data was expressed
as log amount of DNA (fg) for each particular bacterial group per
10 ng of isolated total DNA.
Statistical analysis of sequencing data
The raw sequence data were demultiplexed by barcodes, and
low quality reads were filtered using the QIIME v1.8 (http://
qiime.sourceforge.net) database’s default parameters [26]. A total
of 1,078,487 (median: 35,437; range 22,511–53,163 sequences per
sample) were obtained. For further analysis, each sample was
rarefied to an even sequencing depth of 22,500 sequences per
sample to adjust for uneven sequencing depth across all samples.
Sequences were then clustered into operational taxonomic units
(OTUs) using a closed-reference OTU picking protocol at the
97% sequencing identity level using UCLUST [27] against the
Greengenes database, pre-clustered at 97% sequence identity
[28,29]. Data was uploaded to the database of the National Centre
for Biotechnology Information (NCBI) (accession number
SRP043386).
The compiled data were used to determine the relative
percentages of bacteria for each individual sample. Alpha
rarefaction and beta diversity measures were calculated and
plotted using QIIME. Differences in microbial communities
between groups were investigated using the phylogeny-based
unweighted UniFrac distance metric. This analysis measures the
phylogenetic distance among bacterial communities in a phyloge-
netic tree, and thereby provides a measure of similarity among
microbial communities present in different biological samples. The
groups considered for analysis were (i) diabetic versus non-diabetic
cats; (ii) domestic shorthair cats versus cats of other breeds; (iii)
male versus female cats; (iv) cats aged ten years or less versus cats
greater than ten years of age; (v) protein content of the diet:
moderate (6.0–10.4 grams of protein per 100 kcal metabolisable
energy (ME)) versus high (10.5–13.1 grams of protein per 100 kcal
ME); (vi) carbohydrate content of the diet: low (2.9–4.9 grams of
carbohydrate per 100 kcal ME) versus moderate (5.0–12.5 grams
of carbohydrate per 100 kcal ME); (vii) fat content of the diet: low
(3.6–4.9 grams of fat per 100 kcal ME) versus moderate (5.0–6.4
grams of fat per 100 kcal ME). Differences in microbial
communities between these groups were investigated by visual
assessment for clustering using principal coordinates analysis
(PCoA) plots, and by analysis of similarity (ANOSIM) calculated
on unweighted UniFrac distances using the statistical software
package PRIMER 6 (PRIMER-E Ltd, Luton, UK) [30].
Differences in the median ages of diabetic versus non-diabetic
cats were examined by two-sided Mann-Whitney U tests (IBM
SPSS Statistics, Version 22, IBM Corp., Armonk, NY, USA).
Differences in the proportions of bacteria (defined as median
percentage of total sequences) by phyla, class, order, family, and
genus between diabetic and non-diabetic cats were assessed by
two-sided Mann-Whitney U tests (IBM SPSS Statistics, Version
22, IBM Corp., Armonk, NY, USA). Only groups present in at
least 50% of cats were included in this analysis. The ratio of
Bacteroidetes to Firmicutes in each cat was calculated and a linear
regression model was used to assess for an association between this
ratio and the presence of diabetes mellitus. P values ,0.05 were
considered statistically significant.
Statistical analysis of qPCR data
The mean counts of each bacterial group in diabetic versus non-
diabetic cats, and cats aged ten years or less versus cats greater
than ten years old, were compared by 2-sample t tests (IBM SPSS
Statistics, Version 22, IBM Corp, Armonk, New York, USA). P
values ,0.05 were considered statistically significant.
Results
Study population
A total of 30 (ten diabetic and 20 non-diabetic) cats were
enrolled into the study. Signalment and dietary information of
these cats is summarised in Table 2. Ten of the non-diabetic cats
(cats 11–20) were breed, age- and sex-matched to diabetic cats,
and these cats formed the control group for comparison of the
microbiota between diabetic and non-diabetic cats. The remaining
ten non-diabetic cats (cats 21–30) were included in analysis of the
effects of signalment and dietary factors on microbiota composi-
tion.
Composition of faecal microbiota as determined by
sequencing of the 16S rRNA gene
The predominant bacterial phyla in all cats were Firmicutes,
Actinobacteria and Bacteroidetes; together these phyla comprised
on average greater than 98% of the total bacterial sequences
(mean 98.29%, standard deviation (SD) 3.66%). The predominant
bacterial orders in diabetic and non-diabetic cats are shown in
Figure 1. Table 3 summarises the proportions of bacteria by
phyla, class, order, family, and genus in diabetic and non-diabetic
cats. There was no significant difference in the relative proportions
of any of these taxa between diabetic and non-diabetic cats. The
ratio of Bacteroidetes to Firmicutes was not significantly associated
with the presence of diabetes mellitus (P=0.174).
Rarefaction analysis was performed at a uniform depth of
22,500 sequences per sample. No significant differences in alpha
Figure 1. Median percentage of bacterial orders identified in
diabetic and non-diabetic cats.
doi:10.1371/journal.pone.0108729.g001
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Table 3. Relative proportions of predominant bacterial taxa identified by sequencing of the 16S rRNA gene.
Median percentage of sequences
Diabetic cats (minimum-maximum) Non-diabetic cats (minimum-maximum) P-value
PHYLUM
Actinobacteria 8.79 (1.60–38.42) 9.90 (3.82–34.94) 0.273
Bacteroidetes 0.15 (0.06–2.62) 0.47 (0.11–3.85) 0.061
Euryarchaeota 0.01 (0.00–14.13) 0.01 (0.00–0.02) 0.393
Firmicutes 83.79 (59.82–97.68) 89.44 (64.85–95.18) 0.470
Fusobacteria 0.02 (0.00–1.51) 0.01 (0.00–0.19) 0.381
Proteobacteria 0.18 (0.06–9.64) 0.17 (0.07–1.05) 0.470
Tenericutes 0.04 (0.02–0.16) 0.04 (0.01–0.08) 0.912
CLASS
Actinobacteria (class) 0.29 (0.04–38.24) 1.78 (0.08–33.94) 0.406
Bacilli 1.89 (0.16–51.59) 3.44 (0.20–41.43) 0.650
Bacteroidia 0.15 (0.06–2.62) 0.47 (0.11–3.85) 0.121
Betaproteobacteria 0.01 (0.00–1.51) 0.01 (0.00–0.02) 0.821
Clostridia 78.79 (8.20–96.92) 71.49 (31.64–94.15) 0.406
Coriobacteria 6.88 (0.18–16.38) 6.49 (1.00–21.37) 0.880
Deltaproteobacteria 0.04 (0.01–0.19) 0.04 (0.02–0.23) 0.521
Erysipelotrichi 0.13 (0.04–6.28) 0.19 (0.01–23.40) 0.623
Fusobacteria 0.02 (0.00–1.51) 0.01 (0.00–0.19) 0.762
Gammaproteobacteria 0.08 (0.03–9.59) 0.07 (0.03–0.75) 0.821
Methanobacteria 0.01 (0.00–14.09) 0.00 (0.00–0.00) 0.241
ORDER
Actinomycetales 0.13 (0.02–38.15) 0.07 (0.03–0.49) 0.597
Bacillales 0.03 (0.01–42.42) 0.03 (0.00–1.99) 0.970
Bacteroidales 0.15 (0.06–2.62) 0.47 (0.11–3.85) 0.121
Bifidobacteriales 0.08 (0.12–8.72) 1.68 (0.04–33.91) 0.096
Burkholderiales 0.01 (0.00–1.51) 0.01 (0.00–0.02) 0.821
Clostridiales 78.79 (8.20–96.92) 71.49 (31.64–94.15) 0.406
Coriobacteriales 6.88 (0.18–16.38) 6.49 (1.00–21.37) 0.880
Enterobacteriales 0.08 (0.03–9.59) 0.04 (0.02 –0.75) 0.307
Erysipelotrichales 0.13 (0.04–6.28) 0.19 (0.01–23.40) 0.623
Fusobacteriales 0.02 (0.00–1.51) 0.01 (0.00–0.19) 0.762
Lactobacillales 0.53 (0.12–21.2) 3.37 (0.14–40.89) 0.364
Methanobacteriales 0.01 (0.00–14.09) 0.00 (0.00–0.01) 0.241
Turicibacterales 0.09 (0.02–15.60) 0.10 (0.04–4.47) 0.940
FAMILY
Actinomycetaceae 0.08 (0.00–0.33) 0.04 (0.00–0.26) 0.684
Alcaligenaceae 0.01 (0.00–1.51) 0.01 (0.00–0.02) 0.853
Bacteroidaceae 0.05 (0.03–2.40) 0.24 (0.04–3.69) 0.089
Bifidobacteriaceae 0.08 (0.02–8.72) 1.68 (0.04–33.91) 0.105
Carnobacteriaceae 0.01 (0.00–6.08) 0.01 (0.00–0.05) 0.190
Clostridiaceae 22.96 (2.70–38.04) 22.79 (1.75–41.30) 0.796
Clostridiaceae unclassified 11.33 (0.40–20.20) 10.88 (4.84–14.32) 0.739
Coriobacteriaceae 6.88 (1.18–16.38) 6.49 (1.00–21.37) 0.912
Corynebacteriaceae 0.02 (0.00–0.07) 0.02 (0.00–0.32) 0.579
Desulfovibrionaceae 0.04 (0.01–0.19) 0.04 (0.02–0.23) 0.529
Enterobacteriaceae 0.08 (0.03–9.59) 0.04 (0.02–0.75) 0.315
Enterococcaceae 0.32 (0.05–2.26) 0.58 (0.06–40.59) 0.631
Erysipelotrichaceae 0.13 (0.04–6.28) 0.19 (0.01–23.40) 0.631
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Table 3. Cont.
Median percentage of sequences
Diabetic cats (minimum-maximum) Non-diabetic cats (minimum-maximum) P-value
Eubacteriaceae 0.02 (0.00–0.47) 0.02 (0.00–5.82) 0.436
Fusobacteriaceae 0.02 (0.00–1.51) 0.01 (0.00–0.19) 0.796
Lachnospiraceae 36.35 (0.73–54.23) 20.38 (9.03–63.18) 0.143
Lactobacillaceae 0.08 (0.03–0.12) 0.08 (0.03–32.52) 0.971
Methanobacteriaceae 0.01 (0.00–0.14) 0.00 (0.00–0.01) 0.247
Micrococcaceae 0.02 (0.00–35.67) 0.01 (0.00–0.04) 0.481
Mogibacteriaceae 0.04 (0.00–0.33) 0.04 (0.00–8.18) 0.529
Peptococcaceae 0.06 (0.01–4.69) 2.07 (0.03–9.64) 0.089
Peptostreptococcaceae 2.10 (0.17–15.67) 1.76 (0.16–21.31) 0.853
Planococcaceae 0.00 (0.00–12.31) 0.01 (0.00–0.18) 0.579
Porphyromonadaceae 0.00 (0.00–0.19) 0.02 (0.00–0.30) 0.143
Ruminococcaceae 1.54 (0.00–9.21) 1.55 (0.00–12.01) 0.684
Staphylococcaceae 0.03 (0.01–28.60) 0.02 (0.00–1.72) 0.971
Streptococcaceae 0.04 (0.01–20.99) 0.05 (0.01–9.30) 0.796
Turicibacteraceae 0.09 (0.02–15.60) 0.10 (0.04–4.47) 0.971
GENUS
Actinomyces 0.08 (0.00–0.33) 0.04 (0.00–0.24) 0.684
Anaerofustis 0.02 (0.00–0.46) 0.00 (0.00–0.28) 0.218
Arthrobacter 0.02 (0.00–35.66) 0.01 (0.00–0.04) 0.631
Bacteroides 0.05 (0.03–2.40) 0.24 (0.04–3.69) 0.089
Bifidobacterium 0.02 (0.00–6.15) 0.03 (0.01–33.55) 0.105
Bifidobacterium unclassified 0.06 (0.00–2.57) 0.88 (0.02–19.76) 0.105
Blautia 12.44 (0.16–19.60) 9.61 (2.68–28.83) 0.739
Candidatus Arthromitus 0.00 (0.00–0.02) 0.00 (0.00–1.76) 0.796
Carnobacterium 0.01 (0.00–5.22) 0.01 (0.00–0.04) 0.684
Catenibacterium 0.01 (0.00–0.07) 0.02 (0.00–21.76) 0.315
Clostridium 7.15 (0.95–22.55) 3.97 (0.13–13.53) 0.247
Clostridium unclassified 1 11.33 (0.40–20.20) 10.88 (4.84–14.32) 0.739
Clostridium unclassified 2 13.34 (0.31–28.11) 14.60 (0.56–32.82) 0.971
Collinsella 5.52 (0.12–15.02) 5.91 (0.40–20.15) 0.796
Coprococcus 0.49 (0.02–14.87) 1.08 (0.13–5.17) 0.190
Coriobacterium unclassified 0.06 (0.00–1.39) 0.28 (0.02–1.03) 0.218
Corynebacterium 0.02 (0.00–0.07) 0.02 (0.00–0.32) 0.579
Dorea 3.25 (0.04–9.46) 2.55 (0.46–7.29) 0.529
Enterobacteriacium unclassified 0.08 (0.03–9.59) 0.04 (0.02–0.75) 0.353
Enterococcus 0.32 (0.05–2.26) 0.58 (0.06–40.59) 0.631
Epulopiscium 0.01 (0.00–1.23) 0.01 (0.00–0.95) 0.579
Erysipelothrix unclassified 0.00 (0.00–1.52) 0.00 (0.00–0.18) 0.739
Eubacterium 0.03 (0.01–6.20) 0.06 (0.00–1.79) 0.393
Fusobacterium 0.02 (0.00–1.51) 0.01 (0.00–0.19) 0.796
Lachnospira unclassified 13.15 (0.19–36.15) 6.63 (2.24–23.55) 0.218
Lactobacillus 0.07 (0.03–0.11) 0.06 (0.02–14.06) 0.739
Lactococcus 0.01 (0.00–0.10) 0.01 (0.00–9.16) 0.739
Methanobrevibacter 0.01 (0.00–0.12) 0.00 (0.00–0.01) 0.315
Mogibacterium unclassified 0.04 (0.01–0.33) 0.04 (0.00–8.18) 0.529
Oscillospira 0.19 (0.13–0.45) 0.25 (0.16–1.00) 0.280
Parabacteroides 0.00 (0.00–0.19) 0.02 (0.00–0.30) 0.143
Pediococcus 0.01 (0.00–0.02) 0.01 (0.00–18.47) 0.393
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diversity were observed for any of the evaluated parameters
(Figure 2).
Principal coordinates analysis plots based on the unweighted
UniFrac distance metric are shown in Figure 3 (diabetic versus
non-diabetic cats) and Figure 4. ANOSIM calculated on the
unweighted UniFrac distance metric identified no significant
differences in the UniFrac distances between diabetic and non-
diabetic cats (P=0.84), or between any of the other signalment or
dietary factors considered (Table 4).
qPCR evaluation of the faecal microbiota
The mean counts of each bacterial group in diabetic and non-
diabetic cats are summarised in Table 5. The mean counts of each
bacterial group in cats aged ten years or younger and cats aged
greater than ten years are summarised in Table 6. Faecalibacter-
ium spp. were significantly lower in cats greater than ten years of
age (mean 6 SD 5.3860.96) compared with cats ten years of age
or younger (mean 6 SD 6.3960.74) (P=0.035). No differences in
the mean counts of the other bacterial groups on the basis of
diabetes or age were identified.
Discussion
This study is the first to describe the faecal microbiota
composition of cats with diabetes mellitus, and contributes to
existing knowledge of the feline gastrointestinal microbiota. In our
study, Firmicutes was the predominant bacterial phylum in both
diabetic and non-diabetic cats, and Firmicutes, Actinobacteria and
Bacteroidetes together represented on average greater than 98%
of total bacteria sequenced in both groups. These results are
consistent with those of Handl et al. [12], who used 16S rRNA
gene pyrosequencing to describe the faecal microbiota of 12
healthy pet cats. They also reported that greater than 99% of total
bacteria identified belonged to the phyla Firmicutes, Actinobac-
teria and Bacteroidetes, although the percentage contributions by
each individual phylum (Firmicutes 92%, Actinobacteria 7.3%,
Bacteroidetes 0.45%) differed from that of our study.
In general, there is agreement that Firmicutes, Actinobacteria
and Bacteroidetes are dominant bacterial phyla in feline faecal
samples [11]. However, descriptions of the feline microbiota vary
between studies, likely as determination of the relative abundances
of bacteria is influenced by sample population, the sample
handling, and also the molecular technique that is employed
[25,31]. Actinobacteria was determined to be the most prevalent
bacterial phylum in feline faecal samples when an alternative
target gene (the chaperonin (cpn60) gene) was amplified for
sequencing [10], and when investigated by fluorescent in situ
hybridisation [32,33]. Inter-laboratory differences in DNA
extraction, sample handling, and storage protocols are also
potential sources of variation between studies [34]. Further
confounding interpretation of results is the fact that the
composition of the microbiota varies along the gastrointestinal
tract, and consequently faecal microbiota may not be represen-
tative of the microbiota in the various segments of the
gastrointestinal tract [31,34,35]. These factors complicate study
of the gastrointestinal microbiota, and direct comparison of results
between studies may be problematic. However, comparison of the
composition of the microbiota between groups of animals within a
study such as ours is not subject to as many of these limitations,
and is likely to generate more meaningful results.
Our results showed that the presence of insulin-treated diabetes
mellitus in cats does not affect faecal microbiota composition, as
evaluated by the UniFrac distance metric or by comparison of
relative abundances of predominant bacterial taxa identified by
sequencing of the 16S rRNA gene. We were therefore unable to
replicate the results of Serino et al. [20] who described a decreased
proportion of Firmicutes in mice with type 2 diabetes mellitus, or
Larsen et al. [22] who reported a similar finding in type 2 diabetic
men, in cats with diabetes mellitus. It is possible that the inability
to identify a difference in microbiota composition between diabetic
and non-diabetic cats could have been due to the relatively small
sample size in this study; however, previous studies that have
reported compositional differences of the microbiota associated
with obesity [16], type 2 diabetes [22] and type 1 diabetes [36]
Table 3. Cont.
Median percentage of sequences
Diabetic cats (minimum-maximum) Non-diabetic cats (minimum-maximum) P-value
Peptococcus 0.05 (0.01–4.69) 2.07 (0.02–9.63) 0.105
Peptostreptococcus unclassified 2.07 (0.16–15.65) 1.66 (0.05–21.17) 0.796
Pseudoramibacter Eubacterium 0.00 (0.00–0.01) 0.00 (0.00–5.82) 0.393
Roseburia 0.02 (0.00–0.29) 0.11 (0.01–0.42) 0.247
Ruminococcus 1 0.25 (0.02–5.80) 0.80 (0.16–2.35) 0.190
Ruminococcus 2 0.08 (0.02–0.32) 0.07 (0.04–1.07) 0.684
Ruminococcus unclassified 1.28 (0.11–8.55) 1.18 (0.48–11.13) 0.853
Slackia 0.20 (0.04–1.34) 0.44 (0.03–1.02) 0.796
SMB53 0.09 (0.00–0.37) 0.07 (0.00–0.18) 0.796
Sporosarcina 0.00 (0.00–10.50) 0.01 (0.00–0.16) 0.684
Staphylococcus 0.03 (0.01–28.60) 0.02 (0.00–1.72) 0.971
Streptococcus 0.03 (0.01–20.97) 0.02 (0.00–3.49) 0.579
Turicibacter 0.09 (0.02–15.60) 0.10 (0.04–4.47) 0.971
Differences in median percentages between diabetic and non-diabetic cats were calculated using Mann-Whitney U tests. P values ,0.05 were considered significant.
doi:10.1371/journal.pone.0108729.t003
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Figure 2. Rarefaction analysis of 16S rRNA gene sequences obtained from faecal samples divided into diabetic, signalment and
dietary groups. A: Diabetic status (blue: diabetic, red: non-diabetic); B: Age (blue: cats greater than ten years of age, red: cats aged ten years or less);
C: Breed (blue: DSH, red: Burmese, yellow: Siamese); D: Sex (blue: male, red: female); E: Protein content of diet (blue: N/A, red: high (10.5–13.1 grams of
protein per 100 kcal metabolisable energy (ME)), yellow: moderate (6.0–10.4 grams of protein per 100 kcal ME)); F: Carbohydrate content of diet (blue:
N/A, red: low (2.9–4.9 grams of carbohydrate per 100 kcal ME), yellow: moderate (5.0–12.5 grams of carbohydrate per 100 kcal ME)); G: Fat content of
diet (blue: moderate (5.0–6.4 grams of fat per 100 kcal ME), red: low (3.6–4.9 grams of fat per 100 kcal ME), yellow: N/A).
doi:10.1371/journal.pone.0108729.g002
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Figure 3. Principal coordinates analysis (PCoA) of unweighted UniFrac distances of 16S rRNA. Blue: diabetic cat, red: non-diabetic cat.
doi:10.1371/journal.pone.0108729.g003
Figure 4. Principal coordinates analysis (PCoA) of unweighted UniFrac distances of 16S rRNA. A: Age (blue: cats greater than ten years of
age, red: cats aged ten years or less); B: Breed (blue: DSH, red: Burmese, yellow: Siamese); C: Sex (blue: male, red: female); D: Protein content of diet
(blue: N/A, red: high (10.5–13.1 grams of protein per 100 kcal metabolisable energy (ME)), yellow: moderate (6.0–10.4 grams of protein per 100 kcal
ME)); E: Carbohydrate content of diet (blue: N/A, red: low (2.9–4.9 grams of carbohydrate per 100 kcal ME), yellow: moderate (5.0–12.5 grams of
carbohydrate per 100 kcal ME)); F: Fat content of diet (blue: moderate (5.0–6.4 grams of fat per 100 kcal ME), red: low (3.6–4.9 grams of fat per 100
kcal ME), yellow: N/A).
doi:10.1371/journal.pone.0108729.g004
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have studied a similar number of or fewer individuals, making type
II error unlikely. An additional consideration is that all diabetic
cats in this study were treated with insulin, this being standard
therapy for feline diabetes mellitus. Whether or not exogenous
insulin can alter microbiota composition and/or obscure diabetes-
associated changes in microbiota composition is unknown,
however future studies could explore this issue by studying
diabetic cats at the time of diagnosis, prior to commencement of
insulin therapy.
Compositional analysis of the microbiota, as undertaken in this
study, may overlook the complexities of microbial communities in
vivo. In a recent study, faecal microbiota of children was examined
at several time points up to three years of age, and the microbiota
composition of children who developed anti-islet cell antibodies (a
marker of type 1 diabetes) was compared with children who
remained antibody-free [37]. No differences in microbiota
composition, relative proportions of bacteria at genus level, or
diversity were noted between groups. However when a microbial
correlation network was constructed (by determining correlation
values between all possible genera pairs), a significant difference
was noted in microbial interaction networks between the two
groups of children. It was concluded that despite an absence of
compositional differences, microbial interaction networks were
compromised in children who developed anti-islet cell antibodies.
This study demonstrates that disease-associated alterations of the
faecal microbiota may not necessarily be discernible as quantita-
tive compositional changes; and that consideration of intra-
microbiota relationships may afford a more comprehensive
assessment of the microbiota.
Importantly, failure to identify compositional differences of
faecal microbiota between diabetic and non-diabetic cats does not
exclude the possibility of functional differences of the microbiota in
affected individuals. Host metabolic effects may not be entirely
predictable by a particular microbiota composition, as there is a
large functional overlap in metabolic roles of bacteria within the
gastrointestinal tract [38]. A metagenomic analysis of faecal
microbiota in people with type 2 diabetes demonstrated that the
disease was associated with marked functional alterations of the
microbiota but only moderate compositional change [39]. Future
studies that employ metagenomic, transcriptomic, or metabolo-
mics approaches could identify functional differences of the
microbiota in diabetic cats that are not manifest as an overall
difference in microbiota composition.
The composition of the microbiota has been reported to change
associated with age in humans, with the most consistent change
reported being a decreased total proportion and species diversity
of bifidobacteria in elderly people [40–42]. In cats, the microbiota
composition is more diverse in kittens pre-weaning than post-
weaning [33]. Longer term effects have not been comprehensively
investigated, although one group reported no difference in
bifidobacteria counts of kittens compared with geriatric cats
[43]. Specific age-associated differences in the proportions of
predominant bacterial taxa or Bifidobacterium spp. were not
identified in our study, although Faecalibacterium spp. were
decreased in cats greater than ten years of age. Interestingly,
reduced levels of Faecalibacterium spp. have also been reported in
elderly humans [44,45]. Further studies that compare samples
from very young and very old cats may more readily identify age-
related alterations in microbiota composition of cats.
None of the dietary factors that we evaluated affected faecal
microbiota composition, in contrast to some previous studies
which have related high protein diets to a lower abundance of
Bifidobacterium [33,43,46]. However, the diets investigated in
those studies differed with respect to other nutrients as well as
Table 4. Summary of ANOSIM results for the factors evaluated in this study.
Variable R statistic p-value
Diabetes mellitus 20.0496 0.84
Age 0.1339 0.11
Breed 0.0184 0.42
Sex 20.0455 0.76
Dietary carbohydrate 20.0338 0.68
Dietary fat 0.025 0.36
Dietary protein 20.011 0.45
ANOSIM was calculated using unweighted UniFrac distances. P values ,0.05 were considered significant.
doi:10.1371/journal.pone.0108729.t004
Table 5. Quantitative PCR evaluation of the faecal microbiota in diabetic versus non-diabetic cats.
Mean amount of bacteria
Diabetic cats Non-diabetic cats P-value
All bacteria 11.8660.10 11.7960.23 0.443
Bifidobacterium 4.0661.28 5.3861.75 0.072
Faecalibacterium 5.3361.17 6.0460.69 0.118
Lactobacillus 4.1460.55 4.3360.73 0.517
Values are expressed as means 6 standard deviation of the log amount of DNA (fg) per 10 ng of isolated total DNA. Differences in mean values between diabetic and
non-diabetic cats were determined by 2-sided t-tests. P values ,0.05 were considered significant.
doi:10.1371/journal.pone.0108729.t005
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protein, and the effect of individual dietary components in
isolation has not been scrutinised. All these previous studies have
also utilised laboratory-housed cats, for which dietary and
environmental factors can be more tightly controlled than for
the pet cats in our study. In our study cats were fed a variety of
commercially available diets, many of which were designed to
meet maintenance requirements of adult cats. The variability in
consumed diets also meant that only small groups of cats were
available for comparison for some of the dietary factors
considered, which may have impaired our ability to detect diet-
associated differences. It is possible that with more extreme
differences in nutrient profiles and/or studies involving larger
numbers of cats, diet-related alterations in microbiota composition
would become apparent. Further studies that are specifically
designed to investigate individual nutrient effects are needed to
ascertain the significance of diet in influencing microbiota
composition in cats.
In conclusion, the faecal microbiota composition of insulin-
treated, diabetic cats determined by 16S rRNA gene sequencing
did not differ from that of non-diabetic cats in this study. qPCR
identified a decrease in Faecalibacterium spp. in elderly cats,
similar to observations in elderly humans. There were no
differences in faecal microbiota composition associated with cat
breed or gender, dietary protein, carbohydrate or fat content, or
dietary formulation in our study population of pet cats. Additional
studies that compare the functional products of the microbiota in
diabetic and non-diabetic cats are warranted, to further investigate
the potential pathogenetic role of the gastrointestinal microbiota in
metabolic diseases such as diabetes mellitus in cats.
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